Daypro and Intervertebral disc degeneration - a phase IV clinical study of FDA data

Summary:

Intervertebral disc degeneration is reported as a side effect among people who take Daypro (oxaprozin), especially for people who are female, 50-59 old, also take Aredia, and have Breast cancer.

The phase IV clinical study analyzes which people have Intervertebral disc degeneration when taking Daypro. It is created by eHealthMe based on reports of 2,818 people who have side effects when taking Daypro from the FDA, and is updated regularly.

What is Daypro?

Daypro has active ingredients of oxaprozin. It is often used in osteoarthritis. eHealthMe is studying from 2,883 Daypro users. Check the latest studies of Daypro.

What is Intervertebral disc degeneration?

Intervertebral disc degeneration (spinal disc degeneration) is found to be associated with 1,312 drugs and 1,500 conditions by eHealthMe. Check the latest studies of Intervertebral disc degeneration.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 09, 2026

2,818 people reported to have side effects when taking Daypro.
Among them, 27 people (0.96%) have Intervertebral disc degeneration.

Could Daypro cause Intervertebral disc degeneration?

Among these 27 people:

What is the gender of people who have Intervertebral disc degeneration when taking Daypro? *

female: 85.19 %
male: 14.81 %

What is the age of people who have Intervertebral disc degeneration when taking Daypro? *

What are other drugs people take besides Daypro? *

What are other side effects people have besides Intervertebral disc degeneration? *

Anaemia (lack of blood): 19 people, 70.37%
Joint Pain: 19 people, 70.37%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 18 people, 66.67%
Osteomyelitis (infection of bone): 18 people, 66.67%
Impaired Healing: 18 people, 66.67%
Bone Disorder: 18 people, 66.67%
Osteonecrosis Of Jaw (death of bone of jaw): 18 people, 66.67%
Back Pain: 15 people, 55.56%
Nausea And Vomiting: 14 people, 51.85%
Nausea (feeling of having an urge to vomit): 14 people, 51.85%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 17 people, 62.96%
Breast Cancer: 17 people, 62.96%
Depression: 11 people, 40.74%
Breast Cancer Metastatic: 11 people, 40.74%
Muscle Spasms (muscle contraction): 6 people, 22.22%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.70%
Osteoporosis (bones weak and more likely to break): 1 person, 3.70%
Migraine (headache): 1 person, 3.70%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 3.70%
Impaired Gastric Emptying: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Daypro and have Intervertebral disc degeneration?

- Check whether Intervertebral disc degeneration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Daypro:

Daypro (2,883 reports)

Browse all side effects of Daypro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intervertebral disc degeneration:

Intervertebral disc degeneration (1,312 drugs)

Browse all the conditions that are associated with Intervertebral disc degeneration:

Intervertebral disc degeneration (1,500 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxaprozin (the active ingredients of Daypro) and Daypro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.